1. Home
  2. SYF vs NTRA Comparison

SYF vs NTRA Comparison

Compare SYF & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SYF

Synchrony Financial

HOLD

Current Price

$73.57

Market Cap

25.5B

Sector

Finance

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$212.26

Market Cap

29.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYF
NTRA
Founded
1932
2003
Country
United States
United States
Employees
20000
N/A
Industry
Finance: Consumer Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.5B
29.1B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
SYF
NTRA
Price
$73.57
$212.26
Analyst Decision
Buy
Strong Buy
Analyst Count
19
15
Target Price
$84.83
$259.07
AVG Volume (30 Days)
3.4M
1.3M
Earning Date
04-21-2026
05-07-2026
Dividend Yield
1.60%
N/A
EPS Growth
N/A
0.65
EPS
N/A
N/A
Revenue
N/A
$210,939,000.00
Revenue This Year
$84.92
$18.08
Revenue Next Year
$5.11
$19.65
P/E Ratio
$7.85
N/A
Revenue Growth
N/A
N/A
52 Week Low
$60.01
$131.81
52 Week High
$88.77
$256.36

Technical Indicators

Market Signals
Indicator
SYF
NTRA
Relative Strength Index (RSI) 56.23 51.37
Support Level $72.47 $186.96
Resistance Level $75.15 $222.53
Average True Range (ATR) 2.03 10.51
MACD 0.27 0.34
Stochastic Oscillator 99.07 51.46

Price Performance

Historical Comparison
SYF
NTRA

About SYF Synchrony Financial

Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: